Form 4: Origin Materials GC Granted 400,000 Stock Options

Origin Materials' General Counsel and Chief Compliance Officer, Joshua C. Lee, was granted 400,000 stock options with a vesting schedule extending to 2028.

Summary

• Joshua C. Lee, General Counsel and Chief Compliance Officer of Origin Materials, Inc. (ORGN), was granted 400,000 stock options.
• The options have an exercise price of $0.156 per share.
• Fifty percent (50%) of the options vest on February 17, 2027, and the remaining fifty percent (50%) vest on February 17, 2028, contingent on continued service.
• The stock options are set to expire on March 4, 2036.
• A Power of Attorney dated January 31, 2026, authorizes John Bissell, Matt Plavan, and Joshua Lee to prepare and file SEC forms on behalf of Joshua Lee.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, reflecting standard executive incentive practices and a commitment to retaining key leadership, which is generally favorable for corporate stability and long-term strategic execution.

Positives

• The grant of 400,000 stock options to a key executive aligns management's long-term interests with shareholder value.
• The long-term vesting schedule, extending until 2028, encourages executive retention and sustained performance.
• The exercise price of $0.156 is relatively low, offering potential upside if the company's stock price increases.

Negatives

• The value of the options is contingent on future stock performance, providing no immediate cash benefit to the executive.

Risks

• The ultimate value of the stock options is directly tied to the future market price of Origin Materials, Inc. common stock, which is subject to market volatility.
• Vesting of the options is contingent on Joshua C. Lee's continued service to the company through the specified vesting dates; failure to do so would result in forfeiture of unvested options.

Future Outlook

The grant of stock options with a vesting schedule extending to February 2028 indicates a long-term incentive for the General Counsel and Chief Compliance Officer, aligning their future performance with the company's success and encouraging sustained commitment.

Industry Context

StockSavvy.ai notes that executive stock option grants are a standard practice across industries to incentivize key personnel and align their financial interests with long-term shareholder value. This grant to a General Counsel and Chief Compliance Officer is typical for retaining senior leadership and promoting corporate governance compliance.

Comparison to Industry Standards

• StockSavvy.ai observes that the grant of 400,000 stock options to a General Counsel is a substantial equity award, comparable to grants seen in growth-oriented companies within the materials or renewable chemicals sector.
• Similar grants might be observed at companies like Avantium or Danimer Scientific, where executive compensation often includes significant equity components to drive innovation and market penetration.
• The long vesting period is also standard for encouraging long-term commitment and retention of key executives in competitive industries.

Corporate Governance

Stakeholder Impact

• Shareholders: The option grant aligns the General Counsel's long-term financial interests with shareholder value, potentially leading to more stable and compliant corporate operations.
• Employees: This demonstrates the company's commitment to executive retention and incentivization, which can positively influence overall employee morale and perceived stability within the leadership team.

Next Steps

• Fifty percent of the granted options will vest on February 17, 2027, provided Joshua C. Lee continues to provide services.
• The remaining fifty percent of the granted options will vest on February 17, 2028, provided Joshua C. Lee continues to provide services.

Key Dates

Recommendation

This Form 4 filing details a routine executive stock option grant, which is a standard compensation practice and does not present new information that would significantly alter the investment thesis for Origin Materials. It reinforces management's long-term alignment but does not introduce new fundamental drivers for a 'buy' or 'sell' recommendation.

Keywords

Origin Materials, ORGN, Stock Option, Executive Compensation, SEC Form 4, Insider Transaction, Joshua Lee, Equity Grant, Vesting Schedule